1995 related articles for article (PubMed ID: 31609640)
21. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer.
Berg JW; Hutter RV
Cancer; 1995 Jan; 75(1 Suppl):257-69. PubMed ID: 8001000
[TBL] [Abstract][Full Text] [Related]
23. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival.
Lau M; Le A; El-Serag HB
Am J Gastroenterol; 2006 Nov; 101(11):2485-92. PubMed ID: 17029617
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of histopathology and trends in cervical cancer: a SEER population study.
Vinh-Hung V; Bourgain C; Vlastos G; Cserni G; De Ridder M; Storme G; Vlastos AT
BMC Cancer; 2007 Aug; 7():164. PubMed ID: 17718897
[TBL] [Abstract][Full Text] [Related]
25. Lymph node metastasis in early gastric adenocarcinoma in the United States of America.
Pokala SK; Zhang C; Chen Z; Gamboa AM; Cristofaro SL; Keilin SA; Cai Q; Willingham FF
Endoscopy; 2018 May; 50(5):479-486. PubMed ID: 29228402
[TBL] [Abstract][Full Text] [Related]
26. Urinary system.
Lynch CF; Cohen MB
Cancer; 1995 Jan; 75(1 Suppl):316-29. PubMed ID: 8001003
[TBL] [Abstract][Full Text] [Related]
27. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type.
Henson DE; Dittus C; Younes M; Nguyen H; Albores-Saavedra J
Arch Pathol Lab Med; 2004 Jul; 128(7):765-70. PubMed ID: 15214826
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
29. Annual report to the nation on the status of cancer, part I: National cancer statistics.
Henley SJ; Ward EM; Scott S; Ma J; Anderson RN; Firth AU; Thomas CC; Islami F; Weir HK; Lewis DR; Sherman RL; Wu M; Benard VB; Richardson LC; Jemal A; Cronin K; Kohler BA
Cancer; 2020 May; 126(10):2225-2249. PubMed ID: 32162336
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
31. Shifting proportions of gastric adenocarcinomas.
Salvon-Harman JC; Cady B; Nikulasson S; Khettry U; Stone MD; Lavin P
Arch Surg; 1994 Apr; 129(4):381-8; discussion 388-9. PubMed ID: 7512326
[TBL] [Abstract][Full Text] [Related]
32. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?
Modlin IM; Lye KD; Kidd M
Am J Gastroenterol; 2004 Jan; 99(1):23-32. PubMed ID: 14687136
[TBL] [Abstract][Full Text] [Related]
33. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
34. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract][Full Text] [Related]
35. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
36. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
Islami F; Ward EM; Sung H; Cronin KA; Tangka FKL; Sherman RL; Zhao J; Anderson RN; Henley SJ; Yabroff KR; Jemal A; Benard VB
J Natl Cancer Inst; 2021 Nov; 113(12):1648-1669. PubMed ID: 34240195
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiology of the two types of gastric adenocarcinoma in Iceland according to the Laurén histological classification 1990-2009].
Olafsdottir HS; Alexiusdottir KK; Lund SH; Jonasson JG; Jonsson T; Skuladottir H
Laeknabladid; 2016 Mar; 102(3):125-30. PubMed ID: 26985590
[TBL] [Abstract][Full Text] [Related]
38. Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.
Pokala SK; Zhang C; Chen Z; Gamboa AM; Cristofaro SL; Keilin SA; Cai Q; Willingham FF
J Gastrointest Surg; 2018 Apr; 22(4):569-577. PubMed ID: 29313289
[TBL] [Abstract][Full Text] [Related]
39. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site.
Wu H; Rusiecki JA; Zhu K; Potter J; Devesa SS
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1945-52. PubMed ID: 19531677
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
